Clinical Trial Update: Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating treatment-free remission after asciminib-based therapy in chronic phase chronic myeloid leukemia patients who relapsed after a prior …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Asciminib (asciminib)

Snippet

Sponsor: Medical College of Wisconsin | Conditions: Chronic Phase Chronic Myelogenous Leukemia | Phase 2 | Status: RECRUITING